Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The 6th Annual Oncology Student Symposium was held at St Anne’s College, for the second time, on Monday, 9 July.

© Luana Campos Soares
Prize cover image: “In vivo brain electroporation of nuclear GFP and cytoplasmic tdTomato showed migration of neural stem cells from the subventricular zone following differentiation into glial cells (oligodendrocytes/astrocytes)” - Luana Campos Soares.

The day went really well, and the only complaint about the weather was that it was a bit stuffy in the marquee! Second year students gave their talks in the - thankfully air-conditioned - Mary Ogilvie lecture theatre; and first years presented their posters in the marquee on the lawn in St Anne's Quad. The standard was again agreed to be very high, with clear and confident talks and eye-catching posters which were eloquently explained.


The prizes for the four categories were awarded as follows:

The front cover Image Prize went to Luana Campos Soares (Eric O'Neill and Francis Szele Group) - for the second year running - with "The OLIG-ator" (It was judged blind, so this was complete chance!)

The First Year Poster Presentation Prize went to Richard Baugh (Len Seymour Group) with "Enhancing glioblastoma oncolytic virotherapy with locally delivered macrophage activators" Runners up were Linda van Bijsterveldt (Tim Humphrey and Kate Vallis Group) and Rosalin Cooper (Ben Fairfax and Mark Middleton Group).

The Second Year Oral Presentation Prize was won by Sam Hume (Grigory Dianov and Kristijan Ramadan Group) with "NUCKS nurtures neoplasms". Second place was Timo Reisländer (Madalena Tarsounas Group) and joint third place went to Sally Frost (Len Seymour group and Tzveta Pokrovska (Len Seymour Group).

Best Question Prize during the oral presentations went to Egon Jacobus (Len Seymour Group).

Congratulations to all the prize winners.

Similar stories

Cancer patients remain at higher risk of severe COVID-19 disease despite third dose booster vaccine

A large population-level assessment reveals third dose COVID-19 vaccination is effective for most patients with cancer, but effectiveness is lower than in the general population, particularly in patients who have undergone recent chemotherapy and those with lymphoma.

Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis

Body mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

OUH agrees long COVID research collaboration with Polarean

The collaboration will look at understanding the long-term effects of COVID-19 through cutting-edge MRI analysis.

Lung abnormalities found in long COVID patients with breathlessness

Researchers have identified abnormalities in the lungs of long COVID patients who are experiencing breathlessness that cannot be detected with routine tests.